![Karim Tabiti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karim Tabiti
Vorstandsvorsitzender bei Biotype GmbH
Profil
Karim Tabiti is currently the Director at Anapa Biotech A and Co-Managing Director at Biotype GmbH.
He was previously the Head-Strategic Marketing at Immunodiagnostic Systems Holdings Ltd.
Aktive Positionen von Karim Tabiti
Unternehmen | Position | Beginn |
---|---|---|
Anapa Biotech A/S
![]() Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Direktor/Vorstandsmitglied | - |
Biotype GmbH
![]() Biotype GmbH Medical SpecialtiesHealth Technology Biotype GmbH is a German molecular diagnostics company that specializes in developing, producing, and distributing molecular diagnostic solutions for the detection and quantification of RNA and DNA markers. The private company is based in Dresden, Germany and was founded in 1999 by Jörg Gabert and Wilhelm Zörgiebel. The company's assays support diagnosis and therapy in oncology, haemato-oncology, dermatology, and infectious diseases. The company uses their many years of experience in the development and production of test systems in DNA analysis to set new standards in the area of multiparameter diagnosis for the early and rapid clarification of various medical questions. The company's Mentype® products are essential tools for doctors in the areas of leukemia, oncology, and dermatology. The company has recently offered their expertise in the form of new DNA extraction systems for the preparation of various biological sample materials. Wilhelm Zörgiebel has been the CEO since 1999. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Karim Tabiti
Unternehmen | Position | Ende |
---|---|---|
IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC | Vertrieb & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Immunodiagnostic Systems Holdings Ltd.
![]() Immunodiagnostic Systems Holdings Ltd. Medical SpecialtiesHealth Technology Immunodiagnostic Systems Holdings Plc engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. The company was founded in 1977 and is headquartered in Boldon, the United Kingdom. | Health Technology |
Anapa Biotech A/S
![]() Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Commercial Services |
Biotype GmbH
![]() Biotype GmbH Medical SpecialtiesHealth Technology Biotype GmbH is a German molecular diagnostics company that specializes in developing, producing, and distributing molecular diagnostic solutions for the detection and quantification of RNA and DNA markers. The private company is based in Dresden, Germany and was founded in 1999 by Jörg Gabert and Wilhelm Zörgiebel. The company's assays support diagnosis and therapy in oncology, haemato-oncology, dermatology, and infectious diseases. The company uses their many years of experience in the development and production of test systems in DNA analysis to set new standards in the area of multiparameter diagnosis for the early and rapid clarification of various medical questions. The company's Mentype® products are essential tools for doctors in the areas of leukemia, oncology, and dermatology. The company has recently offered their expertise in the form of new DNA extraction systems for the preparation of various biological sample materials. Wilhelm Zörgiebel has been the CEO since 1999. | Health Technology |